112 related articles for article (PubMed ID: 15661530)
1. p53: a heavily dictated dictator of life and death.
Lu X
Curr Opin Genet Dev; 2005 Feb; 15(1):27-33. PubMed ID: 15661530
[TBL] [Abstract][Full Text] [Related]
2. Transcription regulation by mutant p53.
Weisz L; Oren M; Rotter V
Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
[TBL] [Abstract][Full Text] [Related]
3. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein.
Wadhwa R; Yaguchi T; Hasan MK; Mitsui Y; Reddel RR; Kaul SC
Exp Cell Res; 2002 Apr; 274(2):246-53. PubMed ID: 11900485
[TBL] [Abstract][Full Text] [Related]
4. Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy.
Resnick-Silverman L; Manfredi JJ
J Cell Biochem; 2006 Oct; 99(3):679-89. PubMed ID: 16676359
[TBL] [Abstract][Full Text] [Related]
5. p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics.
Halaby MJ; Yang DQ
Gene; 2007 Jun; 395(1-2):1-7. PubMed ID: 17395405
[TBL] [Abstract][Full Text] [Related]
6. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
Olsson A; Manzl C; Strasser A; Villunger A
Cell Death Differ; 2007 Sep; 14(9):1561-75. PubMed ID: 17627286
[TBL] [Abstract][Full Text] [Related]
7. Regulation of AIF expression by p53.
Stambolsky P; Weisz L; Shats I; Klein Y; Goldfinger N; Oren M; Rotter V
Cell Death Differ; 2006 Dec; 13(12):2140-9. PubMed ID: 16729031
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
11. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
Ju J; Schmitz JC; Song B; Kudo K; Chu E
Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
[TBL] [Abstract][Full Text] [Related]
12. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
Kim E; Giese A; Deppert W
Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
[TBL] [Abstract][Full Text] [Related]
13. The etiology of human cancers.
Kleihues P
Prev Med; 1996; 25(1):13. PubMed ID: 8778752
[No Abstract] [Full Text] [Related]
14. Modifications of p53: competing for the lysines.
Carter S; Vousden KH
Curr Opin Genet Dev; 2009 Feb; 19(1):18-24. PubMed ID: 19179064
[TBL] [Abstract][Full Text] [Related]
15. p53: an overview of over two decades of study.
Cheah PL; Looi LM
Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells.
Nuevemann D; Christgen M; Ungefroren H; Kalthoff H
Oncol Rep; 2006 Sep; 16(3):575-9. PubMed ID: 16865258
[TBL] [Abstract][Full Text] [Related]
17. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
Johnson TM; Attardi LD
Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
[No Abstract] [Full Text] [Related]
18. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
19. Identification of ANKRD11 as a p53 coactivator.
Neilsen PM; Cheney KM; Li CW; Chen JD; Cawrse JE; Schulz RB; Powell JA; Kumar R; Callen DF
J Cell Sci; 2008 Nov; 121(Pt 21):3541-52. PubMed ID: 18840648
[TBL] [Abstract][Full Text] [Related]
20. p53 enters the microRNA world.
Hermeking H
Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
